Literature DB >> 29906749

Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1.

Yuan Yuan1, Gao Haiying2, Li Zhuo2, Lu Ying2, He Xin3.   

Abstract

Non-small cell lung cancer (NSCLC) is one of leading causes of cancer-related death worldwide. Long noncoding RNAs (lncRNAs) has been identified to modulate the tumorigenesis of NSCLC. However, the precise molecular mechanism of lncRNAs in the course is still unclear. Results showed that LINC00339 was significantly up-regulated in NSCLC tissue and cells, which indicated the poor prognosis of NSCLC patients. Loss-of-function experiments showed that LINC00339 silencing inhibited the proliferation and invasion, accelerated the apoptosis, and suppressed the tumor growth of NSCLC cells in vitro and in vivo. Luciferase reporter assay and RNA immunoprecipitation (RIP) revealed that LINC00339 promoted the NSCLC progression via FOXM1 via targeting miR-145. In conclusion, our results identify the important role of the LINC00339/miR-145/FOXM1 axis in the NSCLC tumorigenesis, providing neoteric mechanism for the NSCLC tumorigenesis.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  FOXM1; LINC00339; Non-small cell lung cancer; miR-145

Mesh:

Substances:

Year:  2018        PMID: 29906749     DOI: 10.1016/j.biopha.2018.06.022

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

Review 1.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

2.  hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity.

Authors:  Qizhen Chen; Jiarong Zhang; Yinyan He; Yanqiu Wang
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-22       Impact factor: 8.886

3.  Aspirin ameliorates lung cancer by targeting the miR-98/WNT1 axis.

Authors:  Huizhu Gan; Lin Lin; Nanjun Hu; Yang Yang; Yu Gao; Yu Pei; Kang Chen; Butong Sun
Journal:  Thorac Cancer       Date:  2019-02-12       Impact factor: 3.500

Review 4.  The multifaceted roles of FOXM1 in pulmonary disease.

Authors:  Yumei Li; Feng Wu; Qi Tan; Mengfei Guo; Pei Ma; Xuan Wang; Shuai Zhang; Juanjuan Xu; Ping Luo; Yang Jin
Journal:  Cell Commun Signal       Date:  2019-04-16       Impact factor: 5.712

5.  LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis.

Authors:  Wen Sun; Liwen Zhang; Ranran Yan; Ying Yang; Xiangli Meng
Journal:  Onco Targets Ther       Date:  2019-05-22       Impact factor: 4.147

6.  LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.

Authors:  Wei Peng; Dan He; Bin Shan; Jun Wang; Wenwen Shi; Wenyuan Zhao; Zhenzi Peng; Qingxi Luo; Minghao Duan; Bin Li; Yuanda Cheng; Yeping Dong; Faqing Tang; Chunfang Zhang; Chaojun Duan
Journal:  Cell Death Dis       Date:  2019-07-11       Impact factor: 8.469

7.  Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p/FOXM1 axis in childhood pneumonia.

Authors:  Ping Wang; Haitao Zhang; Weiqing Zhao; Nini Dai
Journal:  BMC Pulm Med       Date:  2021-07-23       Impact factor: 3.317

8.  Silencing long intergenic non-coding RNA 00707 enhances cisplatin sensitivity in cisplatin-resistant non-small-cell lung cancer cells by sponging miR-145.

Authors:  Hongde Zhang; Yi Luo; Wenli Xu; Kang Li; Changzheng Liao
Journal:  Oncol Lett       Date:  2019-10-03       Impact factor: 3.111

9.  Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis.

Authors:  Hongjiang Liu; Chen Li; Jiankai Yang; Yuchen Sun; Shunyao Zhang; Jipeng Yang; Liang Yang; Yuanyu Wang; Baohua Jiao
Journal:  J Cell Mol Med       Date:  2018-09-30       Impact factor: 5.310

10.  MiR-145-targeted HBXIP modulates human breast cancer cell proliferation.

Authors:  Yang Jiang; Dan Wang; Hui Ren; Ying Shi; Yufei Gao
Journal:  Thorac Cancer       Date:  2018-10-31       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.